Sign Up
OverviewAPI
Biocytogen Pharmaceuticals collaborates with Neurocrine Biosciences for the development of human antibodies targeting multiple specifications, granting Neurocrine access to Biocytogen's human antibodies against specified targets with an option to license for production and commercialization worldwide. The collaboration aims to accelerate the development of treatments for difficult-to-treat neurological diseases.

Ask a question